PYX Resources: Achieving volume and diversification milestones. Watch the video here.
Traumakine will be re-positioned for multiple indications in organ protection together with partnerships
· Near term value inflections are expected from the accelerated development of Bexmarilimab
Says it all really Bex is where its at and Organ protection for T.
Near term value inflections nice to see in black and white
We have missed the Covid boat which I think is really poor from the BOD, not saying T won't come good but it was a good opportunity missed.
Bex is really the play now but it feels unless we get some big Pharma interest the wait will be much longer.
Anyway Come on Markku or the SSV comment will haunt you !!!!
It all sounds very promising but it's not really new information just presenting it.
We need volume which unfortunately Farn struggle with.
A whiff of big Pharma is what we need.
Come on Markku SSV is definitely not here yet.
Probably best just to appease Putin.
Appeasement has a history of working well in Europe.
Give him Crimea and the 2 Dombass Regions and it won't be long before he pushes the boundaries again.
What next a breakaway region in Scotland
Switch of money here away from Russian opportunities...will be in the 20s soon.